New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.
New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.
CCTAVE EVENTS
February 27 - March 1, 2025
West Palm Beach, Florida
The MSDA Test provided critical disease activity insights that supported a provider’s decision to initiate disease-modifying therapy (DMT) for an MS patient.
The MSDA Test provided key disease activity insights that supported a provider’s decision to deescalate their patient's DMT. By confirming stable or reduced disease activity, the test gave clinicians confidence to adjust treatment while maintaining disease control.
Chief Revenue Officer
SVP, Business Dev. & Partnerships
SVP, Biomarker R&D
Sr. Medical Director
National Sales Director
Head of Medical Affairs
Sr. Medical Science Liasion
The Octave® MSDA Test measures the levels of 18 proteins in your blood. The results are presented in a report shared with your doctor, which contains an overall disease activity score and four biological pathway scores reported as Low (1.0-4.0), Moderate (4.5-7.0) and High (7.5-10.0). Included in the report are also the individual 18 protein measurements with their respective scores.
The Octave® MSDA Test is designed to measure the likelihood of new MS lesions seen on MRI scans. If you have a disease activity score that is High, you are more likely to have new MRI lesions than if you have a Low or Moderate score.1 These scores often change over time, so it’s important to repeat testing on an ongoing basis. Moreover, the pathway scores can provide you and your provider more insight about your disease activity.
The Octave® MSDA Test must be ordered by a prescribing healthcare provider. Talk to your doctor to learn more about how they can order the test for you. Click here for an example to help guide your discussions.
Each clinic has their own protocol for where patients can get their blood drawn. The test is intended to monitor your disease over time, so your doctor may set a schedule for how often you will receive the test in a year.
Your doctor will receive your report with the results approximately 7 days after Octave receives your sample. Your doctor may share the results with you and mutually decide on the best actions.
Octave is actively working to have all health plans to cover this test. Octave offers support to patients in understanding and managing the insurance and billing aspects related to the Octave MSDA Test. Click here to learn more.
